NEURO61

Session information

[held on paper]Oral Session

[O-18] Oral Session 18
Peripheral Neuropathy 2

Yuki Mitani1, Miho Akaza2, Shigenori Kawabata3, Yuko Hoshino3, Toru Sasaki4, Jun Hashimoto4, Taishi Watanabe1,4, Yuki Miyano1, Shinji Sato1, Sukchan Kim1, Yoichiro Takahashi1, Yoshiaki Adachi5, Kensuke Sekihara3, Atsushi Okawa4 (1.Healthcare Business Group, RICOH Company, Ltd., 2.Respiratory and Nervous System Science, Biomedical Laboratory Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 3.Department of Advanced Technology in medicine, Graduate School of Tokyo Medical and Dental University, 4.Department of Orthopedic Surgery, Tokyo Medical and Dental University, 5.Applied Electronics Laboratory, Kanazawa Institute of Technology)

Taro Yamashita1,2,3, Mitsuharu Ueda1,2, Toshiya Nomura1, Masamitsu Okada1, Masayoshi Tasaki1,2, Teruaki Masuda1,2, Yohei Misumi1,2, Kotaro Takamatsu1,3, Konen Obayashi4, Yukio Ando5 (1.Department of Neurology, Kumamoto University Hospital, 2.Amyloidosis Medical Practice Center, Kumamoto University Hospital, 3.Project for Neurological Intractable Disease, Kumamoto University Hospital, 4.Department of Morphological and physiological Sciences, 5.Nagasaki International University, Department of Amyloidosis Research)

Taishi Watanabe1,2, Shigenori Kawabata3, Kensuke Sekihara3, Toru Sasaki1, Yuki Miyano2, Shinji Sato2, Yuuki Mitani2, Takumi Yamaga2, Yoshiaki Adachi4, Atsushi Okawa1 (1.Department of Orthopedic Surgery, Tokyo Medical and Dental University, 2.Healthcare Business Group, RICOH COMPANY, Ltd., 3.Department of Advanced Technology of Medicine, Tokyo Medical and Dental University, 4.Applied Electronics Laboratory, Kanazawa Institute of Technology)